Academia Sinica yesterday said that its researchers have developed an antibody testing method for COVID-19 and have made progress synthesizing remdesivir, a medicine that many believe could cure the infection.
The Centers for Disease Control on Tuesday sent serum samples to Academia Sinica of three people who had contact with Taiwan’s first COVID-19 fatality, as part of an effort to determine the source of that infection.
The three had tested negative for RNA viruses, but the centers hoped to discover if they had developed antibodies.
Photo courtesy of Academia Sinica
Test results showed that only one sample had antibodies for COVID-19 and SARS, Academia Sinica Institute of Biomedical Sciences research fellow Lin Yi-ling (林宜玲) said.
The sample was obtained from a Taiwanese businessperson who was not listed as a confirmed case, because their immune system beat the virus, she said.
Little is known about COVID-19, so it is still a mystery whether a person who has recovered from it can contract it again, she added.
The method is useful in tracing the transmission chain of a certain case, Institute of Plant and Microbial Biology Director Wu Shu-hsing (吳素幸) said, but added that testing for RNA viruses tells whether a person contracts COVID-19.
Using molecular biology and genetic engineering, Wu said that she pieced together plasmids — a kind of DNA for expressing antigens — in small templates to make up longer series of plasmids for producing the antigens used to test for COVID-19, SARS and Middle East respiratory syndrome antibodies.
Ordering massive plasmid series from overseas manufacturers takes two to three weeks, Lin said, praising Wu’s team for only needing a week.
After Institute of Biological Chemistry associate research fellow Ho Meng-chiao (何孟樵) purified the nucleocapsid protein of COVID-19 for making reagents, Lin used the western blot method to place the antigens in a serum sample for testing antibody reactions, she said.
Another team led by Institute of Chemistry associate research fellow Chein Rong-jie (陳榮傑) succeeded in synthesizing 100mg of remdesivir in two weeks.
Unable to obtain the raw materials in time, they used materials on hand and molecule synthesis, referencing public-domain literature, to make the drug, which on Thursday was 97 percent as pure as the original, Chein said.
Before the centers tasked them with the mission, Academia Sinica President James Liao (廖俊智) last month formed a task force to speed up the development of antigens, antibodies, drugs and vaccines for COVID-19.
The synthesized drug cannot be used without the consent of the US pharmaceutical firm that manufactures remdesivir, Liao said.
Nonetheless, the achievement showed that Academia Sinica is capable of drug synthesis and could facilitate mass production of the drug after a technology transfer has been completed, he added.
Taiwan Semiconductor Manufacturing Co (TSMC, 台積電), the world’s largest foundry service provider, yesterday said that global semiconductor revenue is projected to hit US$1.5 trillion in 2030, after the figure exceeds US$1 trillion this year, as artificial intelligence (AI) demand boosts consumption of token and compute power. “We are still at the beginning of the AI revolution, but we already see a significant impact across the whole semiconductor ecosystem,” TSMC deputy cochief operating officer Kevin Zhang (張曉強) said at the company’s annual technology symposium in Hsinchu City. “It is fair to say that in the past decade, smartphones and other mobile devices were
US-CHINA SUMMIT: MOFA welcomed US reassurance of no change in its Taiwan policy; Trump said he did not comment when Xi talked of opposing independence US President Donald Trump yesterday said he has not made a decision on whether to move forward with a major arms package for Taiwan after hearing concerns about it from Chinese President Xi Jinping (習近平). Trump’s comments on Taiwan came as he flew back to Washington after wrapping up critical talks in which both leaders said important progress was made in stabilizing US-China relations even as deep differences persist between the world’s two biggest powers on Iran and Taiwan. “I will make a determination,” Trump said, adding: “I’ll be making decisions. But, you know, I think the last thing we need right
TAIWAN ISSUE: US treasury secretary Scott Bessent said on the first day of meetings that ‘it wouldn’t be a US-China summit without the Taiwan issue coming up’ There were no surprises on the first day of the summit between US President Donald Trump and Chinese President Xi Jinping (習近平), the Mainland Affairs Council (MAC) said yesterday, as the government reiterated that cross-strait stability is crucial to the Asia-Pacific region, as well as the world. As the two presidents met for a highly anticipated summit yesterday, Chinese state media reported that Xi warned Trump that missteps regarding Taiwan could push their two countries into “conflict.” Trump arrived in China with accolades for his host, calling Xi a “great leader” and “friend,” and extending an invitation to visit the White House
SECURITY: Taipei presses the US for arms supplies, saying the arms sales are not only a reflection of the US security commitment to Taiwan but also serve as a mutual deterrent against regional threats Taiwan is committed to preserving the cross-strait “status quo” and contributing to regional peace and stability, the Presidential Office said yesterday. “It is an undeniable fact that the Republic of China is a sovereign and independent democratic nation,” Presidential Office spokeswoman Karen Kuo (郭雅慧) reiterated, adding that Beijing has no right to claim sovereignty over Taiwan. The statements came after US President Donald Trump warned against Taiwanese independence. Trump wrapped up a state visit to Beijing on Friday, during which Chinese President Xi Jinping (習近平) had pressed him not to support Taiwan. Taiwan depends heavily on US security backing to deter China from carrying
RSS